Horowitz, Michael

Glucagon-like peptides 1 and 2 in health and disease: A review

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 100

Evidence that nitric oxide mechanisms regulate small intestinal motility in humans

Russo, A., Fraser, R., Adachi, K., Horowitz, M., & Boeckxstaens, G. (1999) · Gut

Gastrointestinal motility and disordersNitric Oxide and Endothelin Effects

Cited by 92

The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients

Nguyen, N. Q., Fraser, R. J., Bryant, L. K., Burgstad, C., Chapman, M. J., Bellon, M., Wishart, J., Holloway, R. H., & Horowitz, M. (2008) · Critical Care Medicine

Clinical Nutrition and GastroenterologyGastrointestinal motility and disorders

Cited by 90

Diabetic Gastroparesis: Diagnosis and Management

Ma, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Drugs

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 87

Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control

Jalleh, R. J., Jones, K. L., Rayner, C. K., Marathe, C. S., Wu, T., & Horowitz, M. (2022) · Diabetologia

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 87

The Effects of Critical Illness on Intestinal Glucose Sensing, Transporters, and Absorption*

Deane, A. M., Rayner, C. K., Keeshan, A., Cvijanovic, N., Marino, Z., Nguyen, N. Q., Chia, B., Summers, M. J., Sim, J. A., van Beek, T., et al. (2014) · Critical Care Medicine

Clinical Nutrition and GastroenterologyHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 84

Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids

Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 84

The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: A randomized controlled trial

Thazhath, S. S., Marathe, C. S., Wu, T., Chang, J., Khoo, J., Kuo, P., Checklin, H. L., Bound, M. J., Rigda, R. S., Crouch, B., et al. (2016) · Diabetes

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 83

Gastric emptying in diabetes mellitus: relationship to blood-glucose control

Kong, M.-F., & Horowitz, M. (1999) · Clinics in Geriatric Medicine

Gastrointestinal motility and disordersDiabetes Management and Research

Cited by 80

Upper and/or lower gastrointestinal adverse events with glucagon‐like peptide‐1 receptor agonists: Incidence and consequences

Horowitz, M., Aroda, V. R., Han, J., Hardy, E., & Rayner, C. K. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 79

Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes

Jones, K. L., Rigda, R. S., Buttfield, M. D. M., Hatzinikolas, S., Pham, H. T., Marathe, C. S., Wu, T., Lange, K., Trahair, L. G., Rayner, C. K., et al. (2019) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 66

New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut

Wu, T., Horowitz, M., & Rayner, C. K. (2017) · Expert Review of Gastroenterology & Hepatology

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 64

Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility

Jalleh, R. J., Marathe, C. S., Rayner, C. K., Jones, K. L., Umapathysivam, M. M., Wu, T., Quast, D. R., Plummer, M. P., Nauck, M. A., & Horowitz, M. (2024) · Endocrinology

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 61

Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes

Horowitz, M., Rayner, C. K., & Jones, K. L. (2013) · Advances in Therapy

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 58

Effect of Critical Illness on Triglyceride Absorption

Ali Abdelhamid, Y., Cousins, C. E., Sim, J. A., Bellon, M. S., Nguyen, N. Q., Horowitz, M., Chapman, M. J., & Deane, A. M. (2015) · Journal of Parenteral and Enteral Nutrition

Clinical Nutrition and GastroenterologyHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 55

Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up

Quan, C., Talley, N. J., Jones, M. P., Spies, J., & Horowitz, M. (2008) · The American Journal of Gastroenterology

Gastrointestinal motility and disordersDiabetes Management and Research

Cited by 55

Pharmacokinetic Considerations in Gastrointestinal Motor Disorders

Hebbard, G. S., Sun, W. M., Bochner, F., & Horowitz, M. (1995) · Clinical Pharmacokinetics

Gastrointestinal motility and disordersDrug Solubulity and Delivery Systems

Cited by 51

The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

Jalleh, R. J., Talley, N. J., Horowitz, M., & Nauck, M. A. (2026) · Journal of Clinical Investigation

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 40

Gut mechanisms linking intestinal sweet sensing to glycemic control

Kreuch, D., Keating, D. J., Wu, T., Horowitz, M., Rayner, C. K., & Young, R. L. (2018) · Frontiers in Endocrinology

Biochemical Analysis and Sensing TechniquesGastrointestinal motility and disorders

Cited by 40

Gastrointestinal autonomic neuropathy in diabetes

Marathe, C. S., Jones, K. L., Wu, T., Rayner, C. K., & Horowitz, M. (2020) · Autonomic Neuroscience

Gastrointestinal motility and disordersCardiovascular Syncope and Autonomic Disorders

Cited by 38

Prognosis of diabetic gastroparesis—a 25-year evaluation

Chang, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetic Medicine

Gastrointestinal motility and disordersGastrointestinal Bleeding Diagnosis and Treatment

Cited by 37

Glucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptying

Horowitz, M., Rayner, C. K., Marathe, C. S., Wu, T., & Jones, K. L. (2020) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 32

Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus

Talley, N. J., Howell, S., Jones, M. P., & Horowitz, M. (2002) · American Journal of Gastroenterology

Gastrointestinal motility and disordersDiabetes Management and Research

Cited by 32

Hypoglycaemia and gastric emptying

Marathe, C. S., Marathe, J. A., Rayner, C. K., Kar, P., Jones, K. L., & Horowitz, M. (2019) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchGastrointestinal motility and disorders

Cited by 32